Related Experiment Video
Updated: Aug 13, 2026
Flow Cytometry Protocols for Surface and Intracellular Antigen Analyses of Neural Cell Types
Published on: December 18, 2014
Clinical applications of flow cytometry. Immunologic methods for measuring cell membrane and cytoplasmic antigens
1Laboratory of Flow Cytometry, Roswell Park Cancer Institute, Buffalo, NY 14263.
Insights
Flow cytometry is a key tool for diagnosing leukemia and lymphomas. Combining flow cytometry with other data enhances diagnostic accuracy and patient care, especially for difficult cases.
Area of Science:
- Hematology
- Immunology
- Medical Diagnostics
Background:
- Flow cytometry is the primary method for classifying leukemia and lymphomas.
- Accurate diagnosis relies on integrating flow cytometric data with clinical and morphometric information.
- Current limitations exist in detecting intracellular proteins due to nonspecific antibody binding and biological noise.
Purpose of the Study:
- To highlight the utility of flow cytometry in diagnosing hematologic malignancies.
- To discuss the advantages of flow cytometry, including speed, cell-by-cell analysis, and multi-marker evaluation.
- To emphasize the benefits of combining flow cytometry with histologic findings for improved diagnostic confidence.
Main Methods:
- Utilizing specific antibodies labeled with different fluorochromes for precise disease monitoring.
- Designing antibody panels to track residual disease.
- Performing cell-by-cell analysis and simultaneous evaluation of multiple markers.
Main Results:
- Flow cytometry enables precise classification of leukemia and lymphomas.
- Combined approaches significantly increase diagnostic confidence compared to single methods.
- The method allows for comprehensive analysis using minimal clinical material.
Conclusions:
- Flow cytometry, especially when integrated with other diagnostic data, offers superior precision in classifying hematologic cancers.
- Future applications promise significant improvements in diagnosis and patient management.
- Addressing challenges in intracellular protein detection could further enhance its reliability.
Abstract:
Flow cytometric analysis is the method of choice for classifying leukemia and lymphomas. When combined with other clinical and morphometric data, a definitive diagnosis can be made in the most difficult cases. By using a combination of specific antibodies that are each labeled with a different fluorochrome, panels can be designed to follow residual disease with greater precision than any other method. The detection of intracellular proteins is less well developed. Because antibodies can bind nonspecifically to dead cell components, there may be considerable biological noise. This noise reduces the sensitivity for detecting the desired protein within the cell. Until this problem is solved, it is likely that other methods may provide more reliable data. The major advantages of flow cytometry are rapid cell processing, cell by cell analysis, and the simultaneous evaluation of multiple markers. The latter is especially important because more tests can be performed using less clinical material. When flow cytometric results are combined with histologic results, the confidence in professional interpretation is far greater than either can provide alone. It is likely that the future application of these approaches will significantly improve diagnosis and patient care.
